Sabra Healthcare REIT Announces 2024 Distribution Tax Treatment and Shareholder Guidance

Sabra Healthcare REIT Outlines 2024 Distribution Tax Treatment for Shareholders

Sabra Health Care REIT, Inc. has announced its tax treatment for the distributions planned for 2024, providing clarity on the classification and implications for shareholders. The company intends to distribute a total of $1.20 per share throughout the year, with four quarterly payments of $0.30 scheduled for February 29, May 31, August 30, and November 29. Each distribution will consist predominantly of ordinary dividends, with approximately 88.33% classified as total ordinary dividends and 11.67% as non-dividend distributions. This transparent approach to dividend classification is crucial for shareholders to understand the potential tax implications of their investments.

The breakdown of the distributions reveals that $0.2649911 per share will be categorized as ordinary dividends, which qualify as both non-qualified and qualified dividends. The remaining $0.0350089 will be recorded as non-dividend distributions. Shareholders should be mindful that to qualify for the non-qualified ordinary dividends classified as Section 199A Dividends, they must hold their shares for at least 45 days. This requirement emphasizes the importance of strategic timing in managing investment portfolios, particularly for those looking to optimize their tax positions in light of these distributions.

In addition to the dividend announcements, Sabra confirms compliance with Treasury Regulation § 1.1061-6(c), reporting $0.00 for both the One Year Amounts Disclosure and the Three Year Amounts Disclosure for direct and indirect holders of applicable partnership interests. This level of transparency not only reassures investors about the company's regulatory adherence but also reinforces Sabra's commitment to providing timely and relevant information to its shareholder base. Shareholders are advised to consult their tax advisors to navigate the implications of these distributions effectively.

In related news, Sabra Health Care REIT continues to focus on its core mission of investing in properties that serve the healthcare sector across the United States and Canada. As a self-administered and self-managed real estate investment trust (REIT), the company remains a pivotal player in the healthcare real estate landscape, fostering growth and stability in an essential industry. The clarity surrounding its 2024 distributions underscores Sabra’s commitment to its shareholders, ensuring they are well-informed about their investment returns and tax obligations.